Sepsis News and Research

RSS
Sepsis is a life-threatening illness. Your body's response to a bacterial infection usually causes it. Your immune system goes into overdrive, overwhelming normal processes in your blood. The result is that small blood clots form, blocking blood flow to vital organs. This can lead to organ failure. Babies, old people and those with weakened immune systems are most likely to get sepsis. But even healthy people can become deathly ill from it.
Severe maternal morbidities highly linked to pregnant woman's risk of death

Severe maternal morbidities highly linked to pregnant woman's risk of death

Researchers develop technique to disrupt communication between microorganisms

Researchers develop technique to disrupt communication between microorganisms

Antibiotic resistance likely to kill 2.4 million across Europe, Australia and North America by 2050

Antibiotic resistance likely to kill 2.4 million across Europe, Australia and North America by 2050

Predictive model could improve sepsis care

Predictive model could improve sepsis care

Elderly LS-SCLC patients show similar results to younger counterparts for concurrent chemo-radiotherapy

Elderly LS-SCLC patients show similar results to younger counterparts for concurrent chemo-radiotherapy

Novel technique potentially more effective in fighting against ovarian cancer

Novel technique potentially more effective in fighting against ovarian cancer

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

Researchers use neutrons to explore complex outer surfaces of E.coli

Researchers use neutrons to explore complex outer surfaces of E.coli

New diagnostic platform simultaneously screens for all known pathogenic bacteria

New diagnostic platform simultaneously screens for all known pathogenic bacteria

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Mice study shows antibiotics are not always necessary to cure sepsis

Mice study shows antibiotics are not always necessary to cure sepsis

Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut

Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut

Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis

Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis

Potential 'early warning markers' for sepsis discovered

Potential 'early warning markers' for sepsis discovered

Prevalence of virulent K. pneumoniae strains among neonates is higher than was previously thought

Prevalence of virulent K. pneumoniae strains among neonates is higher than was previously thought

Prenatal inflammation may explain why some infants are more prone to neonatal sepsis

Prenatal inflammation may explain why some infants are more prone to neonatal sepsis

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma